Back to list

Irene Bozzoni

Researcher - Principal Investigator
Senior researcher

Research Line

Non coding RNAs in Physiology and Pathology

Center

CLNS@SAPIENZA Roma

Contacts

+39 010 2897 624
3356404259

About

 

Education

1979: Specialization in General Pathology (70/70).

1975:  MS Degree with honours in Biology, University of Rome (110/110 cum aude)

Current Positions

Since 1994: Full Professor of Molecular Biology, University of Rome.

Since 2018:  Senior Researcher at the Italian Institute of Technology (IIT).

Academic career and research experience

2002:               Visiting Professor at the University of Brandeis, Boston – USA (Prof. M. Rosbash),

1994-present:  Full Professor of Molecular Biology, University of Rome  

1993:               Visiting Professor at the University of Boulder, Colorado - USA (Prof. O. Uhlenbeck)

1986-1994:      Associate Professor of Molecular Biology, University of Rome

1986:               Visiting Professor at the National Institute of Health of Bethesda (USA)

1980-1986:      Staff scientist at the Center for Nucleic Acid Research, CNR, Rome, Italy

1985:               Visiting Scientist at the University of Zurich - CH (Prof.M. Birnstiel)

1978-1980:      Research fellow at the Centro Acidi Nucleici of C.N.R., Rome

1979:               EMBO fellow at the European Molecular Biology Laboratory, Heidelberg( - Germany (Dr. M.L. Melli)

1977-78:          Post-doctoral fellow - Institute of Molecular Biology, University of Zurich -CH (Prof.M. Birnstiel)

Academic assignments

Since 2020: Honorary Fellow at the School for Advanced Studies of Sapienza University of Rome

2016-2018:      Director of the School for Advanced Studies of Sapienza

2007- 2018:     Director of the Master Degree in Genetics and Molecular Biology – Sapienza, University of Rome.

2011-2016:      Deputy Director of the School of Advanced Studies of Sapienza

2000-2016:      Member of the PhD Committee of Sapienza University.

2011-2014:      President of the Evaluation Committee of the Faculty of Sciences, Sapienza University of Rome.

2009-2012:      Member of the Committee for the Innovation of Research and Technology, Sapienza University

2005-2016:      Rappresentative of Sapienza University at the “Consorzio Interuniversitario per le Biotecnologie”.

2007- 2015:     Member of the Technical and Scientific Committee of the Consorzio Sapienza Innovazione of the University La   Sapienza and of the Italian Federation for Life Sciences.

Non academic engagements

Since 2020: member of the “Scientific Advisory Committee” of the European Molecular Biology Laboratory (EMBL)

2018-present:  Member of the “Management Committee” of the Human Technopole.

2018-present:  Member of the Advisory Committee dell'Armenise-Harvard Foundation.

2017-present:  Member of the Board of the “Museo Nazionale della Scienza e della Tecnologia, Leonardo da Vinci",

Milan.

2015- present: Member of the Scientific Advisory Board of the “Enciclopedia Treccani”.

2012-2018:      Review panel member of the Rita Levi-Montalcini “Program on Young Researchers” of the Ministry of Research and University (MIUR).

2016-2018:      Member of the National Committee for the abilitation of Full Professors and Associate Professors in Molecular Biology

2016:               ERC - Review panel member for ERC, LS3 Consolidator Grants (CoG)

2011-2014:      Member of the Review panel member of the membership committee of EMBO

2010-2013:      Member of the Scientific Advisory Board of the “Committee of Experts for the Research Policy” (CEPR), consultant of the of the Italian Ministry of University and Research

2009-2012:      Member of the Scientific Advisory Board of the Pezcoller Foundation

2005-2008:      Member of the Scientific Advisory Board of Armenise-Harvard Foundation

2000-2003:      Member of the Scientific Advisory Board of the “Fondazione Chiara D'Onofrio”

Evaluator for: ESF, AERES, Welcome Trust, EMBO, HFSP, Armenise-Harvard Foundation, AFM and several international scientific institutions.

Memberships, honors and awards

  • In 2013 was awarded of an ERC-Advanced Grant
  • In 2010 was awarded the "Sapienza Ricerca Award"
  • In 2008 was invited to give the “Lectio magistralis” for the inauguration of the academic year at Sapienza, University of Rome
  • In 2003 and 2006 was awarded two Prizes by the Accademia Nazionale dei Lincei.
  • Member of European Molecular Biology Organization (EMBO) and of the "Academia Europaea"
  • Member of Italian Society for Biophysics and Molecular Biology
  • Member of the “Accademia Medica”

Research projects coordinated:

- European Union - VII Research Framework:

ERC-Advanced Grant - Muncodd

People-MSCA- ITN, RNATRAIN Project

RIGHT, Integrated Project

SIROCCO, Integrated ProjecSP3-

- European Union – Horizon 2020:

2016 -Marie Sklodowska Curie Actions -ITN, “circRTrain

- European Science Foundation (ESF)

- Human Frontier Science Program (HFSP)

- French Muscular Dystrophy Association (AFM-Téléthon) 

- MIUR (PRIN, FIRB)

- Fondazione Telethon

- ARISLA

- Associazione Italiana per la Ricerca Sul Cancro (AIRC)

- Istituto Pasteur, Fondazione Cenci-Bolognetti

- Parent Project ONLUS

- Istituto Italiano di Tecnologie (IIT) –SEED projects

 

Interests

RNA biology

Projects

Currently coordinated research projects:

- H2020 - ERC-2019-SyG

Project: 855923 — ASTRA

“Assembly and phase Transitions of Ribonucleoprotein Aggregates in neurons: from physiology to pathology”

- AIRC –Progetto IG-2019  Id.23053

“Circular RNAs: novel players and biomarkers in tumorigenesis”

- European Union – Horizon 2020:

2016 -Marie Sklodowska Curie Actions -ITN, “circRTrain”

PRIN  2017

Prot. 2017P352Z4

“Non coding RNAs, new players in gene expression regulation: studying their role in neuronal differentiation and in neurodegeneration”

 

Previous

  • European Union - VII Research Framework:

ERC-Advanced Grant - Muncodd

People-MSCA- ITN, RNATRAIN Project

  • Fondazione Telethon
  • Istituto Pasteur, Fondazione Cenci-Bolognetti
  • Arisla
  • HFSP
  • ASM

Selected Publications

Principal fields of interest

Molecular biology of RNA

Fazi F., Rosa A., Fatica A., De Marchis M. L., Gelmetti V., Nervi C. and Bozzoni I. (2005) A mini-circuitry comprising microRNA-223 and transcription factors NFI-A and C/EBP-alfa regulates human granulopoiesis. Cell, 123: 819-831.

Cesana M., Cacchiarelli D.Legnini I., Santini T., Sthandier O., Chinappi M., Tramontano A. and Bozzoni I. (2011) Key ceRNA role for the long non-codingRNA linc-MD1 in the control of muscle differentiation. Cell, 147: 358-369

Fatica A. and Bozzoni I. (2014) Long non-coding RNAs: new players in cell differentiation and development. Nature Review Genetics, 15:7-21

Legnini I., Morlando M., Mangiavacchi A., Fatica A.  and Bozzoni. I.. (2014) A feed forward regulatory loop between the HuR protein and the long non coding RNA linc-MD1 controls early phases of muscle differentiation. Mol. Cell, 53:1–9.

Ballarino M., Morlando M., Fatica A. and Bozzoni I. (2016) Non-coding RNAs in muscle differentiation and musculoskeletal disease. J. Clin Invest, 126: 2021-2030.

Legnini I., Di Timoteo G, Rossi F, Briganti F, Sthandier O, Morlando M, Fatica A, Andronache A, Wade M, Rajewsky N Bozzoni I (2017) – circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis,  Mol Cell, 66:22-37.

Dimartino D., Colantoni A., Ballarino M., Martone J., Danner J., Mariani D., Bruckmann A., Meister G., Morlando M. and Bozzoni I. (2018). The long non coding RNA lnc-31 interacts with Rock1 mRNA and mediates its YB-1-dependent translation. Cell Reports, 23:733-740.

Ballarino M, Cipriano A, Tita R, Santini T, Desideri F, Morlando M, Colantoni A, Carrieri C, Nicoletti C, Musarò A, Carroll DO, Bozzoni I. (2018) Deficiency in the nuclear long noncoding RNA Charme causes myogenic defects and heart remodeling in mice. EMBO J., 37:e99697. doi: 10.15252/embj.201899697.

Rossi F., Legnini I., Megiorni F., Colantoni A., Santini T., Morlando M., Di Timoteo G., Dattilo D., Dominici C. and Bozzoni I. (2019). Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma. Oncogene, 38:3843-3854

Di Timoteo G., Dattilo D., Centrón-Broco A., Colantoni A., Guarnacci M., Rossi F., Incarnato D., Oliviero S., Fatica A., Morlando M. and Bozzoni I. (2020) m6A modification regulates circRNA metabolism. Cell Rep. 31:107641. doi: 10.1016/j.celrep.2020.107641.

 Neuromuscular diseases

Denti M.A., Rosa A., D’Antona G., Sthandier O., De Angelis F.G., Nicoletti C., Allocca M., Pansarasa O., Parente V., Musarò A., Auricchio A., Bottinelli R. and Bozzoni I. (2006) Body-wide gene therapy of Duchenne Muscular Dystrophy in the mdx mouse model. Proc. Natl. Acad. Sci. USA, 103: 3758-3763.

Cacchiarelli D.,  Martone J., Girardi E., Cesana M., Incitti T.,  Nicoletti C., Santini T., Sthandier O., Auricchio A., Musarò A. & Bozzoni I. (2010). microRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway. Cell Metabolism, 12:341-51

Cacchiarelli D., Legnini I. Martone J., D’Amico A., Bertini E. and Bozzoni I. (2011) miRNAs as serum biomarkers for Duchenne Muscular Dystrophy. EMBO Mol Med., 5:258-265.

Martone J., Briganti F., Legnini I., Morlando M., Picillo E., Sthandier O., Politano L. and Bozzoni I. (2016) The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype. Nat Commun. 7:10488.

Martone J., Mariani D., Shamloo S., Santini T., Colantoni A., Setti A.,  Capparelli F.,  Paiardini A., Dimartino D.,  Morlando4 M. and Bozzoni I. (2020) SMaRT lncRNA controls translation of a G-quadruplex containing mRNA antagonizing the DHX36 helicase. EMBO Rep. 21:e49942. doi: 10.15252/embr.201949942.

Lisi M. Castagnetti F., Rosa A., Di Carlo V. Blanco E., Setti A.,  Mariani D., Colantoni A., Santini T., Di Croce L. and Bozzoni I. (2020)  Inherited epigenetic repression of the Celf2a splicing factor mediates the amelioration of a Duchenne phenotype – EMBO Mol. Med. 29:e12063. doi: 10.15252/emmm.202012063.

Di Timoteo G., Dattilo D., Centrón-Broco A., Colantoni A., Guarnacci M., Rossi F., Incarnato D., Oliviero S., Fatica A., Morlando M. and Bozzoni I. (2020) m6A modification regulates circRNA metabolism. Cell Rep. 31:107641. doi: 10.1016/j.celrep.2020.107641.

Neurodegenerative diseases:

Dini Modigliani S, Morlando M, Errichelli L, Sabatelli M, Bozzoni I. (2014). An ALS-associated mutation in the FUS 3'-UTR disrupts a microRNA-FUS regulatory circuitry. Nat Commun. 5:4335-41. 

Lenzi J., De Santis R., de Turris V., Morlando M., Calvo A., Caliendo V., Chiò A., Rosa A. and Bozzoni I. (2015)  ALS mutant FUS protein is recruited into stress granules in induced Pluripotent Stem Cells (iPSCs) derived neurons. Dis. Models and Mech., 8:755-66.

Errichelli L., Dini Modigliani S., Laneve P., Colantoni A., Legnini I., Capauto D., Rosa A., De Santis R., Scarfò R., Giovanna P., Lei L., Caffarelli E., Shneider N., Morlando M. and Bozzoni I. (2017) FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat Commun., 30:14741.

De Santis R., Santini L., Colantoni A. , Peruzzi G., de Turris V., Alfano V., Bozzoni I. and Rosa A. (2017) FUS mutant human motoneurons display altered transcriptome and 2 microRNA pathways with implications for ALS pathogenesis. Stem Cell Reports, 9:1450-1462..

Capauto D., Colantoni A., Lu L., Santini T., Peruzzi G., Biscarini S., Morlando M., Shneider N.A., Caffarelli E., Laneve and Bozzoni I. (2018) A regulatory circuitry between Gria2, miR-409 and miR-495 is affected by ALS FUS mutation in ESC-derived motor neurons. Mol Neurobiology, Feb12, doi: 10.1007/s12035-018-0884-4

Biscarini S., Capauto D., Peruzzi G., Lu L., Colantoni A., Santini T., Shneider N., Caffarelli E., Laneve P. and Bozzoni  I. (2018) Characterization of the lncRNA transcriptome in mESC-derived motor neurons: implications for FUS-ALS. Stem Cell Research, 27:172-179

De Santis R., Alfano V., de Turris V., Colantoni A., Santini L., Garone M.G., Antonacci G., Peruzzi G., Sudria-Lopez E., Wyler E., Anink J.J., Aronica E., Landthaler M., Pasterkamp R.J., Bozzoni I., Rosa A. (2019). Mutant FUS and ELAVL4 (HuD) aberrant crosstalk in Amyotrophic Lateral Sclerosis. Cell Reports. 27, 3818–3831. doi: 10.1016/j.celrep.2019.05.085

Third mission and society

Several patents have been transferred to the industry and one received the “Orphan Drug” designation from EMEA. These discoveries are related to molecules for therapeutic and diagnostic applications. These activities have been carried out under collaborative efforts with patients’ associations (Parent Project).
Granted patents.

  • EP 1644499 – Australia 2004256322 - JP4762897- “siRNA expression system” Licenced to: “Promega”. Inventors: Bozzoni I., Denti M. and Rosa A.
  • EP1501931 - “Chimeric antisense snRNA molecoles against splice junctions of dystrophin and therapeutic implications” Licenced to: “Amsterdam Molecular Therapeutics” (AMT) Inventors: Bozzoni I. and De Angelis G.F.
  • WO 2011/154852 “Modified snRNAs for the use in Therapy” Inventors: Bozzoni I., Incitti T, De Angelis G.F
  • PCT/EP2010/057088 - “miRNA biomarkers for the diagnosis of Duchenne Muscular Dystrophy progression, for monitoring therapeutic interventions and as therapeutics” Licenced to "Ylichron". Inventors: Bozzoni I., Martone J., Cacchiarelli D. and Girardi E.
  • PCT/EP2010/057093 - “miR-31 in Duchenne Muscolar Dystrophy therapy” – Inventors: Bozzoni I., Martone J., Cacchiarelli D. and Incitti T.

Awards

  • In 2013 was awarded of an ERC-Advanced Grant
  • In 2010 was awarded the "Sapienza Ricerca Award".
  • In 2008 was invited to give the “Lectio magistralis” for the inauguration of the academic year at Sapienza, University of Rome
  • In 2003 and 2006 was awarded two Prizes by the Accademia Nazionale dei Lincei.
  • Member of European Molecular Biology Organization (EMBO) and of the "Academia Europaea"
  • Member of Italian Society for Biophysics and Molecular Biology
  • Member of the “Accademia Medica”

INFORMATION NOTICE ON COOKIES

IIT's website uses the following types of cookies: browsing/session, analytics, functional and third party cookies. Users can choose whether or not to accept the use of cookies and access the website. By clicking on "Further Information", the full information notice on the types of cookies will be displayed and you will be able to choose whether or not to accept them whilst browsing on the website
Further Information
Accept and close